HEALTHJun 7 · 20:15 UTCMEDPAGE TODAY

Add-On Orforglipron: Good News for Type 2 Diabetes and Inadequate Glycemic Control

Once-daily orforglipron improved outcomes in adults with type 2 diabetes and inadequate glycemic control, according to the ACHIEVE-5 trial. The drug is an add-on treatment for patients already on insulin glargine.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

OrforgliprontopicACHIEVE-5 trialorganizationtype 2 diabetestopicglycemic controltopicinsulin glarginetopicMedPage Todayorganization

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHMay 12 · 23:06 UTC
Daily pill to help keep weight off after stopping obesity jabs
HEALTHJun 3 · 15:44 UTC
Daily tablet could transform type 2 diabetes treatment, trial finds
HEALTHApr 16 · 03:50 UTC
This cheap drug could help people with type 1 diabetes use less insulin
HEALTHJun 7 · 20:18 UTC
Up to 40% of Diabetes Patients Achieved Normal HbA1c With Retatrutide
HEALTHJun 5 · 12:30 UTC
A New Pill Finally Offers Hope for Pancreatic Cancer
HEALTHMay 7 · 10:11 UTC
Scientists discover why Ozempic works better for some people